Of particular importance here is TGF-β; in contrast to most cytokines, its level was found to be decreased in AML patients [125, 126], and it has been identified to inhibit AML cell proliferation and survival [127, 128]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.